Navan, Inc. <NAVN.O>: Oppenheimer Raises Target Price to $35 From $30
NAVN•Related News
FibroBiologics ships third CYWC628 batch to Australia for Phase 1/2 diabetic foot ulcer trial
FBLG•
BranchOut Food prices 820,588-share follow-on at USD 3.4, raising USD 2.79 million
BOF•
Fed's Goolsbee says tariffs creating 'complicated environment' for policy
SPY•
Entera Bio CEO Toledano joins Cantor Global Healthcare Conference fireside chat
ENTX•
Ardmore Shipping exercises options for two 40,500-dwt Handysize tankers at Wuhu Shipyard
ASC•